| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | IFITM2; Interferon-induced transmembrane protein 2; Dispanin subfamily A member 2c; DSPA2c; Interferon-inducible protein 1-8D |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | The antiserum was produced against synthesized peptide derived from the Internal region of human IFITM2. AA range:1-50 |
| Isotype | |
| Product Type | |
| Reactivity | |
| Storage |
Product Overview
Polyclonal Primary AntibodyAnti-IFITM2 rabbit pAb antibody (, -derived) validated for use in multiple research applications. Targets IFITM2 rabbit pAb in validated species samples.
Antibody Specifications
Scientific Background
induction:By alpha and gamma interferons.,similarity:Belongs to the CD225 family.,
Subcellular Location: Cell membrane ; Single-pass type II membrane protein . Lysosome membrane ; Single-pass type II membrane protein . Late endosome membrane ; Single-pass type II membrane protein .
Safety & Handling
Related Products
Explore our complete catalog of antibodies, ELISA kits, and life science research reagents at BioHippo.
Store at -20°C for long-term storage. For short-term use (up to 4 weeks), store at 4°C. Avoid repeated freeze-thaw cycles. Centrifuge briefly before opening if condensation is visible.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.